secwatch / observer
DBD DIEBOLD NIXDORF, Inc
CIK 0000028823 21 ready 8-Ks latest April 30, 2026, 7:59 PM ET RSS · JSON
Activity: NORMAL 1 filings / 30d vs 1 baseline
Ready 8-Ks 21
Latest filing May 26, 2026, 4:06 PM ET
Top materiality 0.85
Event mix earnings ×9 · other_material ×4 · leadership ×4
Sentiment 11 pos · 0 neg · 10 neu
Latest earnings reported 2026-Q1
Executive change recent →

Recent 8-K filings for DBD

Executive changes

Appointed

Dr. Colin J. Parris

Director
DBD · DIEBOLD NIXDORF, Inc
Effective
2024-08-02
Filed
August 7, 2024, 7:59 PM ET
appointed Dr. Colin J. Parris to the Board, effective immediately, to fill the vacancy created by the increase.
Appointed

Maura A. Markus

Director
DBD · DIEBOLD NIXDORF, Inc
Effective
2024-08-06
Filed
August 7, 2024, 7:59 PM ET
appointed Maura A. Markus to the Board, effective immediately, to fill the vacancy created by the increase.
Appointed

Thomas S. Timko

Executive Vice President and Chief Financial Officer
DBD · DIEBOLD NIXDORF, Inc
Effective
2024-05-17
Filed
April 25, 2024, 7:59 PM ET
On April 19, 2024, Diebold Nixdorf, Incorporated (the “Company”) agreed to an offer letter (the “Offer Letter”) with Thomas S. Timko, pursuant to which Mr. Timko has agreed to serve as Executive Vice President and Chief Financial Officer of the Company.

Earnings & guidance

2026-Q1 EPS reported $0.14 filing →

Materiality & sentiment trend

Max materiality 0.85 · Median 0.70 · Most common event earnings

11 positive 0 negative 10 neutral

source · DBD on sec.gov